IBDEI2TU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47452,1,3,0)
 ;;=3^Burkitt Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47452,1,4,0)
 ;;=4^C83.78
 ;;^UTILITY(U,$J,358.3,47452,2)
 ;;=^5001599
 ;;^UTILITY(U,$J,358.3,47453,0)
 ;;=C83.79^^209^2346^70
 ;;^UTILITY(U,$J,358.3,47453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47453,1,3,0)
 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47453,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,47453,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,47454,0)
 ;;=C83.80^^209^2346^401
 ;;^UTILITY(U,$J,358.3,47454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47454,1,3,0)
 ;;=3^Non-Follicular Lymphoma NEC,Unspec Site
 ;;^UTILITY(U,$J,358.3,47454,1,4,0)
 ;;=4^C83.80
 ;;^UTILITY(U,$J,358.3,47454,2)
 ;;=^5001601
 ;;^UTILITY(U,$J,358.3,47455,0)
 ;;=C83.81^^209^2346^394
 ;;^UTILITY(U,$J,358.3,47455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47455,1,3,0)
 ;;=3^Non-Follicular Lymphoma NEC,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47455,1,4,0)
 ;;=4^C83.81
 ;;^UTILITY(U,$J,358.3,47455,2)
 ;;=^5001602
 ;;^UTILITY(U,$J,358.3,47456,0)
 ;;=C83.82^^209^2346^398
 ;;^UTILITY(U,$J,358.3,47456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47456,1,3,0)
 ;;=3^Non-Follicular Lymphoma NEC,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47456,1,4,0)
 ;;=4^C83.82
 ;;^UTILITY(U,$J,358.3,47456,2)
 ;;=^5001603
 ;;^UTILITY(U,$J,358.3,47457,0)
 ;;=C83.83^^209^2346^396
 ;;^UTILITY(U,$J,358.3,47457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47457,1,3,0)
 ;;=3^Non-Follicular Lymphoma NEC,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47457,1,4,0)
 ;;=4^C83.83
 ;;^UTILITY(U,$J,358.3,47457,2)
 ;;=^5001604
 ;;^UTILITY(U,$J,358.3,47458,0)
 ;;=C83.84^^209^2346^392
 ;;^UTILITY(U,$J,358.3,47458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47458,1,3,0)
 ;;=3^Non-Follicular Lymphoma NEC,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47458,1,4,0)
 ;;=4^C83.84
 ;;^UTILITY(U,$J,358.3,47458,2)
 ;;=^5001605
 ;;^UTILITY(U,$J,358.3,47459,0)
 ;;=C83.85^^209^2346^395
 ;;^UTILITY(U,$J,358.3,47459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47459,1,3,0)
 ;;=3^Non-Follicular Lymphoma NEC,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47459,1,4,0)
 ;;=4^C83.85
 ;;^UTILITY(U,$J,358.3,47459,2)
 ;;=^5001606
 ;;^UTILITY(U,$J,358.3,47460,0)
 ;;=C83.86^^209^2346^397
 ;;^UTILITY(U,$J,358.3,47460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47460,1,3,0)
 ;;=3^Non-Follicular Lymphoma NEC,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47460,1,4,0)
 ;;=4^C83.86
 ;;^UTILITY(U,$J,358.3,47460,2)
 ;;=^5001607
 ;;^UTILITY(U,$J,358.3,47461,0)
 ;;=C83.87^^209^2346^400
 ;;^UTILITY(U,$J,358.3,47461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47461,1,3,0)
 ;;=3^Non-Follicular Lymphoma NEC,Spleen
 ;;^UTILITY(U,$J,358.3,47461,1,4,0)
 ;;=4^C83.87
 ;;^UTILITY(U,$J,358.3,47461,2)
 ;;=^5001608
 ;;^UTILITY(U,$J,358.3,47462,0)
 ;;=C83.88^^209^2346^399
 ;;^UTILITY(U,$J,358.3,47462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47462,1,3,0)
 ;;=3^Non-Follicular Lymphoma NEC,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47462,1,4,0)
 ;;=4^C83.88
 ;;^UTILITY(U,$J,358.3,47462,2)
 ;;=^5001609
 ;;^UTILITY(U,$J,358.3,47463,0)
 ;;=C83.89^^209^2346^393
 ;;^UTILITY(U,$J,358.3,47463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47463,1,3,0)
 ;;=3^Non-Follicular Lymphoma NEC,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47463,1,4,0)
 ;;=4^C83.89
 ;;^UTILITY(U,$J,358.3,47463,2)
 ;;=^5001610
 ;;^UTILITY(U,$J,358.3,47464,0)
 ;;=C83.90^^209^2346^411
 ;;^UTILITY(U,$J,358.3,47464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47464,1,3,0)
 ;;=3^Non-Follicular Lymphoma Unspec,Unspec Site
